Issue link: https://viewer.e-digitaledition.com/i/1429589
Eric M. Genden, MD, MHCA, FACS, Isidore Friesner Professor and Chair of Otolaryngology — Head and Neck Surgery and the Director of the Head and Neck Institute at Mount Sinai Health System, performs a routine oral exam on a patient. THE CULMINATION OF 30 YE ARS OF RESE ARCH, THIS GROUNDBRE AKING SURGERY L AUNCHED THE MOUNT SINAI TR ACHE AL TR ANSPL ANT PROGR AM AND OPENED THE DOOR TO HELPING PATIENTS WORLDWIDE. FOR DECADE S, MEDICAL researchers believed a successful tracheal implant was physically impossible, which narrowed surgical options for patients with diseased or severely damaged tracheas. For patients with intubation damage, airway tumors, congenital tracheal defects and trauma from accidents, treatments did exist — but those treatments came with a high risk of complications, and proved to be only temporary solutions, if they were effective at all. Eric M. Genden, MD, MHCA, FACS, Isidore Friesner Professor and Chair of Otolaryngology — Head and Neck Surgery and the Director of the Head and Neck Institute at Mount Sinai Health System, refused to accept that patients had no bet- ter options. On Jan. 13, Dr. Genden, along with Sander S. Florman, MD, Director of the Recanati/Miller Transplantation Institute at Mount Sinai, and a team of more tha n 50 specia lists, performed the first long-segment donor tracheal transplant at Mount Sinai, laying the foundation for a new era in trachea l treatment and human transplantation. "Now, we have an option for patients who rea l ly d id n't h ave a n opt ion ," Dr. Genden says. "This is an opportunity for life for a lot of patients." CHALLENGING THE IMPOSSIBLE Dr. Genden's passion for helping patients with trachea l damage began when he was a medical student at Washing ton University assisting with a surgery for a benign tracheal tumor. "We began the operation and saw how extensive the damage was," Dr. Genden says. "We realized if we removed six or seven centimeters of trachea, there would be no way to put the patient back together. I was kind of shocked." The surgeons realized the only thing they could do was place a stent, which would be only a palliative solution. The patient eventually died. "I was surprised that in an age when we were transplanting kidneys and livers that there was nothing we could do for what seemed at the time was a simple airway passage," Dr. Genden says. "That was the impetus for my getting involved in this. It was what I felt was an unmet need." D r. G enden de cide d t o d ive i nt o existing resea rch on severe trachea l Eric M. Genden, MD, MHCA, FACS, Leads the First-Ever Human Tracheal Transplant Surgery at Mount Sinai BY ELESA SWIRGSDIN 0 6❱❱❱❱❱ C O V E R F E A T U R E

